Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Sperling

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2007
Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive declineS L Miller, E Fenstermacher, J Bates, et al.
Neurology|April 1, 1995
Plasmapheresis in fulminant acute disseminated encephalomyelitisD S Kanter, D Horensky, R A Sperling, et al.
Human Brain Mapping|September 18, 2001
Encoding novel face-name associations: a functional MRI studyR A Sperling, J F Bates, A J Cocchiarella, et al.
Biomicrofluidics|June 15, 2017
Efficient extraction of oil from droplet microfluidic emulsionsJ R Haliburton, S C Kim, I C Clark, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 StudyD M Rentz, P B Rosenberg, R A Sperling, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 StudyK V Papp, P Maruff, D M Rentz, et al.
Neurology|May 14, 2010
Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical declineJ L O'Brien, K M O'Keefe, P S LaViolette, et al.
The Journal of Prevention of Alzheimer'S Disease|September 13, 2020
Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical TrialsO Langford, R Raman, R A Sperling, et al.
The Journal of Prevention of Alzheimer'S Disease|December 1, 2017
Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 BatteriesR F Buckley, K P Sparks, K V Papp, et al.
The Journal of Prevention of Alzheimer'S Disease|May 29, 2020
The Future of Anti-Amyloid TrialsP S Aisen, J Cummings, R Doody, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2007
Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive declineS L Miller, E Fenstermacher, J Bates, et al.
Neurology|April 1, 1995
Plasmapheresis in fulminant acute disseminated encephalomyelitisD S Kanter, D Horensky, R A Sperling, et al.
Human Brain Mapping|September 18, 2001
Encoding novel face-name associations: a functional MRI studyR A Sperling, J F Bates, A J Cocchiarella, et al.
Biomicrofluidics|June 15, 2017
Efficient extraction of oil from droplet microfluidic emulsionsJ R Haliburton, S C Kim, I C Clark, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 StudyD M Rentz, P B Rosenberg, R A Sperling, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 StudyK V Papp, P Maruff, D M Rentz, et al.
Neurology|May 14, 2010
Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical declineJ L O'Brien, K M O'Keefe, P S LaViolette, et al.
The Journal of Prevention of Alzheimer'S Disease|September 13, 2020
Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical TrialsO Langford, R Raman, R A Sperling, et al.
The Journal of Prevention of Alzheimer'S Disease|December 1, 2017
Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 BatteriesR F Buckley, K P Sparks, K V Papp, et al.
The Journal of Prevention of Alzheimer'S Disease|May 29, 2020
The Future of Anti-Amyloid TrialsP S Aisen, J Cummings, R Doody, et al.
Pageof 6